COP28: Canada Daily Highlights - December 9, 2023
PR Newswire
Today at 7:01pm UTC
KRF Capital’s, inaugural K Energy Growth Equity Fund launches with investment in United States Sail GP Team
GlobeNewsWire
Today at 6:51pm UTC
Swiss Asset Manager Pando Asset Files for Bitcoin ETF, Next 10x Coins – Shiba Inu, Pepe and Everlodge
NewsDirect
Today at 6:40pm UTC
Cogent Biosciences Announces Positive Initial Data from Phase 2 SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic...
GlobeNewsWire
Today at 6:30pm UTC
Last Legend Off the Line: 2023 Chrysler 300C Ends Production
PR Newswire
Today at 6:18pm UTC
FSR INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Fisker Inc. Investors with Substantial Losses Have Opportunity to...
GlobeNewsWire
Today at 6:15pm UTC
Will Ethereum Retest $2,800? Crypto Whales Buy Up Klaytn and Pullix Tokens
NewsDirect
Today at 6:15pm UTC
Crypto Christmas Comes Early as Pre-Holiday Market Heats Up. Where Are the Biggest Gains?
NewsDirect
Today at 6:00pm UTC
The NDC Partnership Joins the COP28 and CBD COP15 Presidencies and Nearly 30 Countries and Coalitions Advancing Integrated Action for...
PR Newswire
Today at 5:59pm UTC
Blueprint Medicines' Leadership in Driving Continued Innovation in Systemic Mastocytosis Highlighted at 2023 ASH Annual Meeting
PR Newswire
Today at 5:30pm UTC
FINTECH.TV AND GLOBAL ALLIANCE FOR A SUSTAINABLE PLANET (GASP) ANNOUNCE PARTNERSHIP TO CATALYZE CHANGE AND ACCELERATE SOLUTIONS
NewsDirect
Today at 5:08pm UTC
International Best-Selling Author of “In God We Trust, the Dollar We Worship,” Pens His Third Book: “Awoken: Conspiracy or Theory?”
WebWire
Today at 5:00pm UTC
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101
GlobeNewsWire
Today at 5:00pm UTC
New Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Shows Strong, Durable Treatment Response for Patients with Difficult-To...
PR Newswire
Today at 5:00pm UTC
X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023
GlobeNewsWire
Today at 5:00pm UTC
Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR...
GlobeNewsWire
Today at 5:00pm UTC
Corvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial
GlobeNewsWire
Today at 5:00pm UTC
TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual...
GlobeNewsWire
Today at 5:00pm UTC
Allogene Therapeutics Presents Comprehensive Safety Data of Proprietary Lymphodepletion Agent ALLO-647 at the 65th Annual Meeting of the...
GlobeNewsWire
Today at 5:00pm UTC
Thomas F. McLoughlin Shares Important Plant Fossil Specimens for Geological Studies
WebWire
Today at 4:37pm UTC